98 related articles for article (PubMed ID: 35269789)
21. Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.
Lee DM; Kim IY; Lee HJ; Seo MJ; Cho MY; Lee HI; Yoon G; Ji JH; Park SS; Jeong SY; Choi EK; Choi YH; Yun CO; Yeo M; Kim E; Choi KS
Cell Death Dis; 2024 Jan; 15(1):48. PubMed ID: 38218922
[TBL] [Abstract][Full Text] [Related]
22. Targeting paraptosis in cancer: opportunities and challenges.
Chen F; Tang H; Cai X; Lin J; Xiang L; Kang R; Liu J; Tang D
Cancer Gene Ther; 2024 Mar; 31(3):349-363. PubMed ID: 38177306
[TBL] [Abstract][Full Text] [Related]
23. Paraptosis: a unique cell death mode for targeting cancer.
Hanson S; Dharan A; P V J; Pal S; Nair BG; Kar R; Mishra N
Front Pharmacol; 2023; 14():1159409. PubMed ID: 37397502
[TBL] [Abstract][Full Text] [Related]
24. Research Progress for Targeting Deubiquitinases in Gastric Cancers.
An T; Lu Y; Gong Z; Wang Y; Su C; Tang G; Hou J
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497313
[TBL] [Abstract][Full Text] [Related]
25. Intracellular Ca
Kim E; Lee DM; Seo MJ; Lee HJ; Choi KS
Front Cell Dev Biol; 2020; 8():607844. PubMed ID: 33585447
[TBL] [Abstract][Full Text] [Related]
26. POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells.
Spataro V; Buetti-Dinh A
Br J Cancer; 2022 Sep; 127(5):788-799. PubMed ID: 35501388
[TBL] [Abstract][Full Text] [Related]
27. PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca
Lee HJ; Lee DM; Seo MJ; Kang HC; Kwon SK; Choi KS
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269789
[TBL] [Abstract][Full Text] [Related]
28. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells.
Seo MJ; Kim IY; Lee DM; Park YJ; Cho MY; Jin HJ; Choi KS
Cell Death Dis; 2023 Jan; 14(1):42. PubMed ID: 36658130
[TBL] [Abstract][Full Text] [Related]
29. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
He L; Yu C; Qin S; Zheng E; Liu X; Liu Y; Yu S; Liu Y; Dou X; Shang Z; Wang Y; Wang Y; Zhou X; Liu B; Zhong Y; Liu Z; Lu J; Sun L
Mol Cell; 2023 Nov; 83(22):4000-4016.e6. PubMed ID: 37935198
[TBL] [Abstract][Full Text] [Related]
30. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
31. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.
Lee DM; Kim IY; Seo MJ; Kwon MR; Choi KS
Exp Mol Med; 2017 Aug; 49(8):e365. PubMed ID: 28798402
[TBL] [Abstract][Full Text] [Related]
32. Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca
Dilshara MG; Neelaka Molagoda IM; Prasad Tharanga Jayasooriya RG; Choi YH; Park C; Kim GY
Arch Biochem Biophys; 2021 Feb; 698():108723. PubMed ID: 33321111
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients.
Xuan DTM; Wu CC; Kao TJ; Ta HDK; Anuraga G; Andriani V; Athoillah M; Chiao CC; Wu YF; Lee KH; Wang CY; Chuang JY
Aging (Albany NY); 2021 Nov; 13(22):24882-24913. PubMed ID: 34839279
[TBL] [Abstract][Full Text] [Related]
34. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
Sun T; Liu Z; Bi F; Yang Q
Mol Oncol; 2021 Dec; 15(12):3639-3658. PubMed ID: 34382324
[TBL] [Abstract][Full Text] [Related]
35. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
